href="https://fonts.googleapis.com/css2?family=Work+Sans:ital,wght@0,200;0,300;0,400;0,500;0,600;0,700;1,200;1,300;1,400;1,500;1,600;1,700&display=swap" rel="stylesheet">
Yıl: 2014 Cilt: 20 Sayı: 1 Sayfa Aralığı: 29 - 33 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats

Öz:
AMAÇ: Ratlarda siklofosfamid ve sisplatinin over rezervi üzerine etkisini; primordial follikül sayısı, oksidan/anti-oksidan durum, TNF-alfa ve 8-OH deguanozin ölçümleri ile değerlerlendirmektir. GEREÇ VE YÖNTEM: Otuz Wistar rat üç gruba ayrılmıştır. Çalışma Ege Üniversitesi Tıp Fakültesi'nde yapılmıştır. Sisplatin 5 mg/kg dozda (sisplatin grup, n=10), siklofosfamid 6 mg/kg dozda (siklofosfamid grup, n=10) ve kontrol grubuna sadece steril salin (kontrol grup, n=10) uygulanmıştır. Tüm enjeksiyonlar tek doz ve intraperitoneal olarak uygulanmıştır. Yedinci günün sonunda intrakardiyak yoldan kan örnekleri alınmış ve her iki over çıkarılmıştır. Primordial follikül sayısı, TNFalfa, 8-OH deoksiguanozin, malondialdehit (MDA) ve katalaz enzim aktivite düzeyleri değerlendirilmiştir. BULGULAR: Primordial follikül sayısı kontrol grubunda, sisplatin grubunda ve siklofosfamid grubunda sırasıyla 27,5±4,7; 17,3±2,1; 17±1,4 idi (p=0,156). TNF-alfa düzeyi sisplatin grubunda anlamlı olarak yüksek olmasına rağmen (p<0,001), 8- OH deoksiguanozin düzeyinde üç grup arasında anlamlı farklılık yoktu (p=0,431). Diğer gruplar ile karşılaştırıldığında, sisplatin grubunda MDA düzeyi anlamlı olarak düşük (p<0,001) iken katalaz enzim aktivitesi istatiksel anlamlı farklılık göstermemekteydi. SONUÇ: Belirtilen dozlarda kullanılan kemoterapötik ilaçlarda az düzeyde primordial folliküllerde azalma görülmüştür. Artmış TNF-alfa ve MDA düzeyleri, over dokusu hasarı gelişmesinde rol oynayabilir.
Anahtar Kelime:

Konular: Kadın Hastalıkları ve Doğum

Ratlarda Kemoterapinin Over Rezervi Üzerine Etkilerinin Değerlendirilmesi

Öz:
OBJECTIVE: To determine the effect of cyclophosphamide and cisplatin on ovarian reserve in rats by the way of counting primordial follicle and assessing TNF-alpha, 8-OH deguanosine and oxidant/ antioxidant status. STUDY DESIGN: Thirty Wistar rats were divided into three groups. Cisplatin was administered at a dose of 5 mg/kg (Cisplatin group, n=10), cyclophosphamide was administered at a dose of 6 mg/kg (Cyclophosphamide group, n=10) and control group was only given sterile saline (Control group, n=10) in Ege University Faculty of Medicine. All injections were administered intraperitoneally at a single dose. At the end of the 7th day blood samples were drawn by intracardiac aspiration and bilateral extirpation of ovaries were performed. The number of primordial follicles, levels of TNF-alpha, 8-OH deoxyguanosine, malondialdehyde (MDA) and catalase enzyme activities were evaluated. RESULTS: The number of primordial follicles in the control group, cisplatin group and cyclophosphamide group were 27.5±4.7;17.3±2.1;17±1.4, respectively (p=0.156). While the levels of TNF-alpha were significantly higher in cisplatin group (p<0,001), 8-OH deoxyguanosine levels did not have significant difference among three groups (p=0.431). The levels of MDA were significantly lower compared to the other groups (p<0.001); however, the catalase enzyme activities did not show statistically significant difference. CONCLUSIONS: Insignificant depletion of primordial follicles was observed by using specified doses of chemotherapeutics. An increase in TNF-alpha and MDA levels may play a role in the development of ovarian tissue damage.
Anahtar Kelime:

Konular: Kadın Hastalıkları ve Doğum
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Guillevin L. Advances in the treatments of systemic vasculitides. Clin Rev Allergy Immunol 2008;35:72-8. 2. Boekelheide K. Mechanisms of toxic damage to spermatogenesis. J Natl Cancer Inst Monogr 2005;1:6-8
  • 3. Mora, LO, Antunes, L.M, Francescato, HD, Bianchi, ML. The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res 2003;47:517-22.
  • 4. Datta K, Chin A, Ahmed T, et al. Mixed effects of 2,6- dithiopurine against cyclophosphamide mediated bladder and lung toxicity in mice. Toxicology 1998;125:1-11
  • 5. Naziroğlu M, Karaoğlu A, Aksoy AO. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 2004;195:221-30.
  • 6. Tsai-Turton M, Luong BT, Tan Y, Luderer U. Cyclophosphamide-induced apoptosis in COV434 human granulosa cells involves oxidative stress and glutathione depletion. Toxicol Sci 2007;98:216-30.
  • 7. Kehrer, JP. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 1993;23:21-48
  • 8. Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2' - deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2009;27:120-39.
  • 9. Alper G, Irer S, Duman E, Caglayan O, Yilmaz C. Effect of I-deprenyl and gliclazide on oxidant stress/antioxidant status and dna damage in a diabetic rat model Endocr Res. 2005;31:199-212.
  • 10. Iborra A, Palacio JR, Martinez P. Oxidative stress and autoimmune response in the infertile woman. Chem Immunol Allergy 2005;88:150-62.
  • 11. Smith BJ. Comparison of random and serial sections in assessment of ovarian toxicity. Reprod Toxicol 1991;5:379- 83. 12. Yagi, K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Res 1976;15:212-216
  • 13. Aebi, H. E. Catalase in: Bergmeyer, H. U (Ed.): Methods of enzymatic analysis 1986;3:273-86
  • 14. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ. Pregnancies following high-dose cycloposphamide with or without high-dose busulfan or totalbody irradiation and bone marrow transplantation. Blood 1996;87:3045-52.
  • 15. Lemos CN, Reis FM, Pena GN, Silveira LC, Camargos AF. Assessment of fertility protection and ovarian reserve with GnRH antagonist in rats undergoing chemotherapy with cyclophosphamide. Reprod Biol Endocrinol 2010; 18:51.
  • 16. Oktem O, Oktay K. Fertility preservation for breast cancer patients. Semin Reprod Med 2009;27:486-92.
  • 17. Meirow D, Lewis H, Nugent D, Epstein M. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod 1999;14:1903-7.
  • 18. Gucer F, Balkanli-Kaplan P, Doganay L et al. Effect of paclitaxel on primordial follicular reserve in mice. Fertil Steril 2001;76:628-9
  • 19. Yucebilgin MS, Terek MC, Ozsaran A, Akercan F, Zekioglu O, Isik E, Erhan Y. Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility Aust N Z J Obstet Gynaecol 2004;44:6-9.
  • 20. Agarwal A, Gupta S, Sharma RK Role of oxidative stress in female reproduction Reprod Med Biol 2005;4:31-44.
  • 21. Yang HW, Hwang KJ, Kwon HC, Kim HS, Choi KW, Oh KS. Detection of reactive oxygen species (ROS) and apoptosis in human fragmented embryos. Hum Reprod 1998;13:998-1002.
  • 22. Paszkowski T, Clarke RN. Antioxidative capacity of preimplantation embryo culture medium declines following the incubation of poor quality embryos. Hum Reprod 1996; 11:2493-2495
  • 23. Zhang X, Li XH, Ma X, Wang ZH, Lu S, Guo YL. Redoxinduced apoptosis of human oocytes in resting follicles in vitro. J Soc Gynecol Investig 2006;13:451-458.
  • 24. Tamura H, Takasaki A, Miwa I, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res 2008;44:280-7.
  • 25. Murdoch WJ, Martinchick JF: Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: carcinogenic implication and chemoprevention. Exp Biol Med 2004;229:546-52.
  • 26. D'Aiuto F, Nibali L, Parkar M, Patel K, Suvan J, Donos N. Oxidative stress, systemic inflammation, and severe periodontitis. J Dent Res 2010;89:1241-6
  • 27. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett 2008;29:287-91.
APA ERGENOĞLU A, YENİEL Ö, TURAN V, DEMİRTAŞ G, AKMAN L, TEREK M, Ercan G, ZEKİOĞLU O (2014). Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats. , 29 - 33.
Chicago ERGENOĞLU Ahmet Mete,YENİEL Özgür,TURAN Volkan,DEMİRTAŞ Gülşah,AKMAN LEVENT,TEREK Mustafa Çoşkun,Ercan Gülinnaz,ZEKİOĞLU Osman Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats. (2014): 29 - 33.
MLA ERGENOĞLU Ahmet Mete,YENİEL Özgür,TURAN Volkan,DEMİRTAŞ Gülşah,AKMAN LEVENT,TEREK Mustafa Çoşkun,Ercan Gülinnaz,ZEKİOĞLU Osman Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats. , 2014, ss.29 - 33.
AMA ERGENOĞLU A,YENİEL Ö,TURAN V,DEMİRTAŞ G,AKMAN L,TEREK M,Ercan G,ZEKİOĞLU O Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats. . 2014; 29 - 33.
Vancouver ERGENOĞLU A,YENİEL Ö,TURAN V,DEMİRTAŞ G,AKMAN L,TEREK M,Ercan G,ZEKİOĞLU O Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats. . 2014; 29 - 33.
IEEE ERGENOĞLU A,YENİEL Ö,TURAN V,DEMİRTAŞ G,AKMAN L,TEREK M,Ercan G,ZEKİOĞLU O "Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats." , ss.29 - 33, 2014.
ISNAD ERGENOĞLU, Ahmet Mete vd. "Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats". (2014), 29-33.
APA ERGENOĞLU A, YENİEL Ö, TURAN V, DEMİRTAŞ G, AKMAN L, TEREK M, Ercan G, ZEKİOĞLU O (2014). Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats. GORM:Gynecology Obstetrics & Reproductive Medicine, 20(1), 29 - 33.
Chicago ERGENOĞLU Ahmet Mete,YENİEL Özgür,TURAN Volkan,DEMİRTAŞ Gülşah,AKMAN LEVENT,TEREK Mustafa Çoşkun,Ercan Gülinnaz,ZEKİOĞLU Osman Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats. GORM:Gynecology Obstetrics & Reproductive Medicine 20, no.1 (2014): 29 - 33.
MLA ERGENOĞLU Ahmet Mete,YENİEL Özgür,TURAN Volkan,DEMİRTAŞ Gülşah,AKMAN LEVENT,TEREK Mustafa Çoşkun,Ercan Gülinnaz,ZEKİOĞLU Osman Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats. GORM:Gynecology Obstetrics & Reproductive Medicine, vol.20, no.1, 2014, ss.29 - 33.
AMA ERGENOĞLU A,YENİEL Ö,TURAN V,DEMİRTAŞ G,AKMAN L,TEREK M,Ercan G,ZEKİOĞLU O Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats. GORM:Gynecology Obstetrics & Reproductive Medicine. 2014; 20(1): 29 - 33.
Vancouver ERGENOĞLU A,YENİEL Ö,TURAN V,DEMİRTAŞ G,AKMAN L,TEREK M,Ercan G,ZEKİOĞLU O Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats. GORM:Gynecology Obstetrics & Reproductive Medicine. 2014; 20(1): 29 - 33.
IEEE ERGENOĞLU A,YENİEL Ö,TURAN V,DEMİRTAŞ G,AKMAN L,TEREK M,Ercan G,ZEKİOĞLU O "Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats." GORM:Gynecology Obstetrics & Reproductive Medicine, 20, ss.29 - 33, 2014.
ISNAD ERGENOĞLU, Ahmet Mete vd. "Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats". GORM:Gynecology Obstetrics & Reproductive Medicine 20/1 (2014), 29-33.